Marilyn Dammerman

1.1k total citations
10 papers, 919 citations indexed

About

Marilyn Dammerman is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Marilyn Dammerman has authored 10 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 4 papers in Molecular Biology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Marilyn Dammerman's work include Lipid metabolism and disorders (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Marilyn Dammerman is often cited by papers focused on Lipid metabolism and disorders (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Marilyn Dammerman collaborates with scholars based in United States, Micronesia and Japan. Marilyn Dammerman's co-authors include Jan L. Breslow, J L Breslow, Lodewijk A. Sandkuijl, Wendy K. Chung, Jeffrey L. Halaas, Bridget Shafit‐Zagardo, Shula Metzger, Todd Leff, Jonathan D. Smith and Kay L. Fields and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Marilyn Dammerman

10 papers receiving 892 citations

Peers

Countries citing papers authored by Marilyn Dammerman

Since Specialization

Citations

This map shows the geographic impact of Marilyn Dammerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilyn Dammerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilyn Dammerman more than expected).

Fields of papers citing papers by Marilyn Dammerman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilyn Dammerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilyn Dammerman. The network helps show where Marilyn Dammerman may publish in the future.

Co-authorship network of co-authors of Marilyn Dammerman

This figure shows the co-authorship network connecting the top 25 collaborators of Marilyn Dammerman. A scholar is included among the top collaborators of Marilyn Dammerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilyn Dammerman. Marilyn Dammerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Absence of Mutations in the Human OB Gene in Obese/Diabetic Subjects 1996 ·Diabetes ·Margherita Maffei, Markus Stoffel, Marisa Barone, Byoung C. Moon, Marilyn Dammerman, Éric Ravussin, Clifton Bogardus, David S. Ludwig, Jeffrey S. Flier, (unknown), (unknown), Jeffrey M. Friedman	134
2	Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. 1995 ·Journal of Clinical Investigation ·(unknown), Marilyn Dammerman, Jonathan D. Smith, Shula Metzger, Jan L. Breslow, Todd Leff	227
3	Genetic Determinants of Myocardial Infarction 1995 ·Advances in experimental medicine and biology ·Jan L. Breslow, Marilyn Dammerman	7
4	An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population 1995 ·Human Genetics ·(unknown), Marilyn Dammerman, (unknown), (unknown), J L Breslow, Jun Sasaki	55
5	Genetic Basis of Lipoprotein Disorders 1995 ·Circulation ·Marilyn Dammerman, Jan L. Breslow	81
6	An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms. 1993 ·Proceedings of the National Academy of Sciences ·Marilyn Dammerman, Lodewijk A. Sandkuijl, Jeffrey L. Halaas, Wendy K. Chung, J L Breslow	201
7	Localization and characterization of the binding site for the regulatory subunit of type II cAMP-dependent protein kinase on MAP2 1989 ·Neuron ·(unknown), Marilyn Dammerman, Bridget Shafit‐Zagardo, Jack Erlichman	116
8	Sequence of a human MAP‐2 region sharing epitopes with Alzheimer neurofibrillary tangles 1989 ·Journal of Neuroscience Research ·Marilyn Dammerman, S. -H. Yen, Bridget Shafit‐Zagardo	26
9	Isolation and characterization of cDNA clones encoding epitopes shared with alzheimer neurofibrillary tangles 1988 ·Journal of Neuroscience Research ·Marilyn Dammerman, Menek Goldstein, S. -H. Yen, Bridget Shafit‐Zagardo	11
10	A monoclonal antibody equivalent to anti-rat neural antigen-1 as a marker for schwann cells 1985 ·Neuroscience ·Kay L. Fields, Marilyn Dammerman	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact